Genovis Investor Relations » Press Releases

August 12, 2021 08:05 (CEST) HALF-YEAR REPORT FOR THE FIRST HALF OF 2021 Regulatory MAR

June 07, 2021 15:02 (CEST) Genovis and GlycoT Therapeutics enter into cross-licensing agreements on novel antibody conjugation technology

May 20, 2021 11:09 (CEST) Communiqué from Genovis AB (publ) Annual General Meeting May 20, 2021 Regulatory

April 29, 2021 12:00 (CEST) Interim Report January – March 2021 Regulatory MAR

April 28, 2021 08:02 (CEST) Genovis Annual Report 2020 published Regulatory

April 14, 2021 13:32 (CEST) NOTICE CONVENING THE 2021 ANNUAL GENERAL MEETING Regulatory

April 13, 2021 14:02 (CEST) Genovis and Waters Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization Regulatory

March 29, 2021 20:09 (CEST) Genovis CFO has resigned Regulatory

March 02, 2021 08:51 (CET) Proposal to expand the Genovis Board of Directors at 2021 AGM Regulatory

February 11, 2021 08:00 (CET) Year-end Report January - December 2020 Regulatory MAR

Press Releases